News

A Message from Dr. Kunkel Dear Colleagues,

In response to President's Schlissel's message on April 20 regarding the university's financial challenges in the face of the COVID-19 pandemic, UMOR has posted a number of new FAQs that address...

Research studies that are funded by NIH are automatically deemed issued a Certificate under the NIH Policy on Certificates of Confidentiality (CoC). The CoC automatically extends as long as the NIH...

On Tuesday, April 14, UMOR hosted a virtual Research Town Hall, which featured updates on the entire U-M research enterprise from Dr. Rebecca Cunningham, Dr. Steven Kunkel, and other U-M research...

Michigan Medicine has many brilliant physicians and scientists with creative ideas on how to better treat or prevent COVID-19. Fortunately, there are fewer COVID-19 patients in our hospital than...

SignNow Software is now HIPAA and FDA 21 CFR Part 11 compliant for patient signatures.

The Medical School has opened a Biosafety Level 3 Lab (BSL3) in Med Sci II, equipped for invitro research. BSL3 is a lab where work can occur involving microbes that can cause serious or potentially...

A message from Dr. Kunkel: Dear Colleagues, As we enter week three of the “ramp down” of on-campus Medical School research operations, I wanted to share with you that there is a significant amount...

All COVID-19 clinical trials must to be submitted to the COVID-19 Research Prioritization Committee and will be assigned as a high priority. Once the designation has been made, Anna Lok, M.D.,...

All U-M research faculty and staff are invited to join Dr. Rebecca Cunningham, U-M VP for Research, Dr. Steven Kunkel, Executive Vice Dean for Research of the Medical School and Chief Scientific...